Amjesh Revikumar

According to our database, Amjesh Revikumar authored at least 4 papers between 2022 and 2025.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of five.

2025

Convolidine as potent BACE1 inhibitor for Alzheimer's disease; in-silico coupled with in-vitro assessment.

Anuroopa G. Nadh, M. Jitha Kunhikrishnan, Vishal Ravi, Krishnapriya Ramakrishnan, Niyas Rehman, Krishna S. B. Adithya, Amjesh Revikumar, P. R. Sudhakaran, Rajesh Raju

J. Comput. Aided Mol. Des., December, 2025

Uncovering human kinase substrates in nipah proteome.

Vineetha Shaji, Akash Anil, Ayisha A. Jabbar, Althaf Mahin, Ahmad Rafi, Amjesh Revikumar, Sowmya Soman, Ganesh Prasad, Sneha M. Pinto, Yashwanth Subbannayya, Abhithaj Jayanandan, Rajesh Raju

Frontiers Bioinform., 2025

In silico identification and characterization of micropeptides with potential therapeutic properties from non-coding DNA of E. coli.

Navya Raj, Saima Anwar Lashari, Amjesh Revikumar, Muhammad Tahir

Comput. Biol. Medicine, 2025

2022

Identification of potential lead compounds against BACE1 through in-silico screening of phytochemicals of Medhya rasayana plants for Alzheimer's disease management.

Anuroopa G. Nadh, Amjesh Revikumar, P. R. Sudhakaran, Achuthsankar S. Nair

Comput. Biol. Medicine, 2022